Bronchoalveolar lavage brings mesenchymal stem cells to the light.

[1]  M. Peters-Golden,et al.  Prostaglandin E2 as an inhibitory modulator of fibrogenesis in human lung allografts. , 2012, American journal of respiratory and critical care medicine.

[2]  M. Burdick,et al.  Circulating fibrocytes correlate with bronchiolitis obliterans syndrome development after lung transplantation: a novel clinical biomarker. , 2011, The Annals of thoracic surgery.

[3]  V. Keshamouni,et al.  Resident tissue-specific mesenchymal progenitor cells contribute to fibrogenesis in human lung allografts. , 2011, The American journal of pathology.

[4]  F. Martinez,et al.  Mesenchymal stromal cells in bronchoalveolar lavage as predictors of bronchiolitis obliterans syndrome. , 2011, American journal of respiratory and critical care medicine.

[5]  D. Pinsky,et al.  Epithelial interactions and local engraftment of lung-resident mesenchymal stem cells. , 2011, American journal of respiratory cell and molecular biology.

[6]  E. White,et al.  Hypermethylation of PTGER2 confers prostaglandin E2 resistance in fibrotic fibroblasts from humans and mice. , 2010, The American journal of pathology.

[7]  A. Nicholson,et al.  Diminished prostaglandin E2 contributes to the apoptosis paradox in idiopathic pulmonary fibrosis. , 2010, American journal of respiratory and critical care medicine.

[8]  L. Bouadma,et al.  Alveolar fibroblasts in acute lung injury: biological behaviour and clinical relevance , 2009, European Respiratory Journal.

[9]  J. Lordan,et al.  Epithelial to mesenchymal transition (EMT) and airway remodelling after human lung transplantation , 2009, Thorax.

[10]  F. Martinez,et al.  Evidence for tissue-resident mesenchymal stem cells in human adult lung from studies of transplanted allografts. , 2007, The Journal of clinical investigation.

[11]  K. Larsen,et al.  BALF-derived fibroblasts differ from biopsy-derived fibroblasts in systemic sclerosis , 2007, European Respiratory Journal.

[12]  A. Fabre,et al.  Defect of pro-hepatocyte growth factor activation by fibroblasts in idiopathic pulmonary fibrosis. , 2006, American journal of respiratory and critical care medicine.

[13]  J. Malmström,et al.  Functional and phenotypical comparison of myofibroblasts derived from biopsies and bronchoalveolar lavage in mild asthma and scleroderma , 2006, Respiratory research.

[14]  F. Martinez,et al.  Variable prostaglandin E2 resistance in fibroblasts from patients with usual interstitial pneumonia. , 2008, American journal of respiratory and critical care medicine.